SCHEMBL5517240

SCHEMBL5517240

CC(=O)NC1=NC(=O)/C(=C/c2ccc3nccc(OC4CCN(C(C)=O)CC4)c3c2)S1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CISD1 Q9NZ45 1/20 0.43
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPT P10636 3/20 0.39
HTT P42858 2/20 0.39
KDM4E B2RXH2 2/20 0.39
RECQL P46063 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.39
RAB9A P51151 1/20 0.39
PIK3CD O00329 2/20 0.38
PIK3CA P42336 2/20 0.38
PIK3CB P42338 2/20 0.38
PIK3CG P48736 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
NSD2 O96028 1/20 0.37
POLB P06746 1/20 0.37
APEX1 P27695 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5503407 0.88 KMT2A (0.44) MEN1KMT2AALDH1A1MAPTRECQL
SCHEMBL14437316 0.78 GPR119 (0.48) MEN1KMT2APIK3CDPIK3CAPIK3CB
SCHEMBL14437267 0.73 CISD1 (0.40) CISD1MEN1KMT2AALDH1A1MAPT
SCHEMBL5499618 0.71 KMT2A (0.44) CISD1MEN1KMT2AALDH1A1MAPT
SCHEMBL14437271 0.69 CISD1 (0.39) CISD1MEN1KMT2AMAPTKDM4E
SCHEMBL14437285 0.69 PDGFRA (0.41) CISD1MEN1KMT2AALDH1A1MAPT
SCHEMBL14437291 0.69 CISD1 (0.39) CISD1MEN1KMT2AMAPTKDM4E
SCHEMBL5502873 0.69 CISD1 (0.41) CISD1MEN1KMT2AALDH1A1MAPT
SCHEMBL14452289 0.69 CISD1 (0.41) CISD1MEN1KMT2AALDH1A1MAPT
SCHEMBL5502878 0.69 CISD1 (0.41) CISD1MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7253285-B2 Thiazolinone 4-monosubstituted quinolines HOFFMANN-LA ROCHE INC. (US) 2007-08-07 US disclosed
US-20060063805-A1 Thiazolinone 4-monosubstituted quinolines CHEN LI 2006-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063805-A1 Thiazolinone 4-monosubstituted quinolines CDK1, CDK14, CDK17 CISD1 905/4885MEN1 1239/4885KMT2A 622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.